Adenocarcinoma in Situ
📧 Sign up to get email alerts when something new happens for Adenocarcinoma in Situ.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females [Phase 3]
Phase 3 trial assessing immunogenicity and safety of a 9-valent HPV recombinant vaccine in Chinese healthy females has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017) [Phase 3]
Phase 3 safety and immunogenicity study of GARDASIL 9 (V503) in 9- to 26-year-old females and males in Vietnam has completed enrollment with…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) [Phase 4]
Phase 4 clinical trial update on V501 in Japanese women (16-26) assessing safety and efficacy; completed with results posted in 2017.